Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced today that Harrison Dillon, Ph.D., the company’s co-founder and President, has decided to step down from his full-time position and shift to a long-term consulting role focused on further developing the breadth of the technology platform and advising on intellectual property strategy.
“The experience of starting a company -- taking an idea, developing a technology and building a team to commercialize it -- has vastly exceeded my expectations. It has also been intense and incredibly focused. I wouldn’t trade the experience for anything, but I am looking forward now to spending more time with my family and recharging,” said Dr. Dillon.
“Harrison’s drive and integrity as well as his scientific creativity and legal skills were key in the formation and development of Solazyme. We are grateful to him for his leadership over the past 10 years, and I am personally grateful to Harrison for his friendship since our earliest days in college. Harrison will continue on this journey with Solazyme as an advisor, consultant, shareholder and friend as we commercialize this technology platform globally,” said Jonathan Wolfson, CEO of Solazyme.
“We have just scratched the surface of what Solazyme’s technology platform will mean to the world. While I am looking forward to a change of pace, I remain committed to helping Solazyme achieve its goals and I am supremely confident in the team running the company,” said Dr. Dillon. As part of his transition, Dr. Dillon has also stepped down from the company’s Board of Directors.About Solazyme, Inc. Solazyme, Inc. (SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils and food ingredients. Headquartered in South San Francisco, Solazyme's renewable products can replace or enhance oils derived from the world's three existing sources — petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) chemicals and fuels, (2) nutrition and (3) skin and personal care.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV